Last month, regular folks teamed up to “short squeeze” shares of GameStop higher, forcing hedge funds betting against the stock to slingshot its share price higher as they escaped their losing bets. Now it’s open season on short sellers — and they’re running scared.
If you are already a subscriber, click the login button below to get access. Not yet a subscriber? Checkout our publication below and get access today!
A new feature will be coming soon to Catalyst Trader. I anticipate many more big catalyst wins to roll in during the coming weeks and months… But I want to supercharge your gain chances!
Our portfolio position has been enjoying some stiff tailwinds to start 2021. Investors are realizing that electric car adoption is likely to accelerate hard over the next few years, driving demand for car companies and suppliers. If you haven’t gotten in on this pick yet, now’s your chance!
With GameStop plummeting back to Earth this week, gangs of traders are on the lookout for the next potential squeeze target. That’s what’s driving today’s massive surge in shares your rare disease biotech play...
Some truly exciting trends are emerging in our Catalyst Trader portfolio! Today, I want to provide you with some longer-form updates than the standard weekly one-liner, plus a look ahead at upcoming catalysts I’m monitoring on our calendar.
Last week, we added a new biotech name to the portfolio. Today, I want to share an exciting update on your other clinical-stage biotech play.
Today I want to provide you a major update on your space SPAC. The votes are in and it could mean big things for your play…